Literature DB >> 1167809

Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation.

R L Noble, B C Hochachka, D King.   

Abstract

Tumors in rats of the Nb strain, arising either spontaneously or after prolonged treatment with s.c. pellets of estrogen, were transplanted to establish whether hormone conditioning was required for their growth. Whereas all spontaneous tumors arising in males and many of those in females were autonomous on transplant, most of those arising in estrogenized rats continued to require hormones for growth after transplantation. The latter included carcinomas of the adrenal cortex, breast, pituitary ectopic tissue, ovary (thecomas), Leydig cells of testis, thymus, pancreas,salivary glands, oribital gland (fibroadenoma), liposarcoma, and lymphoma. Many of the tissues of origin of the tumors have not been considered to be under theinfluence of estrogens. A type of hormone-responsive tumor that was inhibited by estrogen and that grew only in normal rats is described. Ali estrogens tested, including estriol , were interchangeable in action. The incidence of the more common tumors of the adrenal, breast, and pituitary was very low in normal rats, but higher in females. All tumors were more common after estrogenization in both sexes, particularyly in older animals. The secretion of steroids and pitiutary hormones by many tumors led to obvious biological effects. Pituitary secretion led to severe lesions frequently associated with diseases in humans, but the signs of such diseases in the rat apparently were hormone dependent and disappeared if the tumor was removed. The overall results raised the possiblity that estrogens were not carcinogenic per se but stimulated the growth of previously altered cells and that, following their transplantation, this hormone requirement was retained. Irrespective of the mechanism of carcinogenesis, hormone-dependent tumor growth was not irreversible but was controlled in an unexpectedly wide spectrum of organs by exogenous estrogen. Host factors may play a major role in controlling the growth of many tumors and the ultimate course of the disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1167809

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Characterization of K+ currents in rat malignant lymphocytes (Nb2 cells).

Authors:  S Cukierman
Journal:  J Membr Biol       Date:  1992-03       Impact factor: 1.843

2.  Human follicular fluid: prolactin is biologically active and ovum fertilization correlates with estradiol concentration.

Authors:  M G Subramanian; A G Sacco; K S Moghissi; D M Magyar; M F Hayes; D M Lawson; R R Gala
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-06

3.  Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells.

Authors:  Karma C Fussell; Ronald G Udasin; Peter J S Smith; Michael A Gallo; Jeffrey D Laskin
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

Review 4.  Controversies in clinical cancer dormancy.

Authors:  Jonathan W Uhr; Klaus Pantel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

Review 5.  Adrenal tumours are more predominant in females regardless of their histological subtype: a review.

Authors:  François Audenet; Arnaud Méjean; Emmanuel Chartier-Kastler; Morgan Rouprêt
Journal:  World J Urol       Date:  2013-01-09       Impact factor: 4.226

Review 6.  The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis.

Authors:  Xiaomin Lou; Ju Zhang; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal:  Cell Cycle       Date:  2014-05-05       Impact factor: 4.534

Review 7.  Adrenal cortical carcinoma.

Authors:  A P Dackiw; J E Lee; R F Gagel; D B Evans
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

8.  Abnormal oxidative metabolism of estradiol in women with breast cancer.

Authors:  J Schneider; D Kinne; A Fracchia; V Pierce; K E Anderson; H L Bradlow; J Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study.

Authors:  Paras B Singh; Narasimhan Ragavan; Katherine M Ashton; Prabir Basu; Sayeed M Nadeem; Caroline M Nicholson; R K Gopala Krishna; Shyam S Matanhelia; Francis L Martin
Journal:  Asian J Androl       Date:  2009-11-23       Impact factor: 3.285

10.  Giant cavernous hemangioma of the liver and multiple primary malignant tumors in a patient with suspected familial inhibition of natural killer cell activity--a case report.

Authors:  T Tomiyama; K Uchida; K Yoshida; T Muto; H Saito; K Nemoto; Z Inoue; T Morita; H Miyakoshi; K Tamura
Journal:  Jpn J Surg       Date:  1989-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.